There is a risk of stroke associated with taking tibolone in people 64 years of age, and it should be evaluated by a doctor for use.
Tibolone may be used to treat symptoms of low estrogen in women due to natural or surgical menopause. Studies of this product have shown a 2.2-fold increase in the risk of stroke among women using the drug (average age 68). The instructions therefore state that for people over 60 years of age, the risk of stroke needs to be considered.
For all people using this product, the decision to treat with this product should be made by a doctor based on an overall risk assessment.
Adverse reactions to Tibolone can be seen as lower abdominal pain, abnormal hair growth, dizziness, headache, seborrheic dermatitis, rash, and itching. This product is contraindicated in pregnancy, lactation, breast cancer, estrogen-dependent malignant tumors, unexplained vaginal bleeding, untreated endometrial hyperplasia, stroke, acute liver disease, allergy to Tibolone.
It should be used rationally under the guidance of a doctor.